Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat. Pneumonia is one of the prominent infections caused in hospital premises. Cases of hospital acquired pneumonia are common in immunocompromised patients, post surgical infections, enteral feeding, elderly and infant patients. As hospital acquired pneumonia is mainly caused as a result of prolonged exposure to ventilator air, it is also called as ventilator associated pneumonia. Major causative pathogens include methicillin resistant S. aureus (MRSA), multi drug resistant (MDR) P. aeruginosa, Klebsiella and Acinetobacter. Respiratory Syncytial Virus (RSV) has also been found to be a major causative agent of nosocomial pneumonia in new borne.
The report details the trend, potential and market size of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugsmarket, defines the market attractiveness level of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pipeline Analysis of Hospital Acquired Pneumonia Drugs industry, describes the types of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pipeline Analysis of Hospital Acquired Pneumonia Drugs market and the development prospects and opportunities of Pipeline Analysis of Hospital Acquired Pneumonia Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pipeline Analysis of Hospital Acquired Pneumonia Drugs market in Chapter 13.
By Player:
Achaogen
Meiji Seika Pharma
Valneva
AstraZeneca
GlaxoSmithKline
Aridis Pharmaceuticals
Cubist Pharmaceuticals
Merck
Sanofi
By Type:
Tedizolid Phosphate
Ceftolozane/Tazobactam
Ceftazidime/Avibactum
Amikacin Inhale
Plazomicin
Synflorix Vaccine
By End-User:
Bacterial Pneumonia
Viral Pneumonia
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis and Outlook to 2022
-
7.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.2 United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.3 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.4 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.5 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.6 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
-
7.7 South Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (2017-2022)
8 Region and Country-wise Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis and Outlook to 2028
-
8.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.2 United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.4 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.6 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2022-2028)
9 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tedizolid Phosphate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ceftolozane/Tazobactam Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ceftazidime/Avibactum Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Amikacin Inhale Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Plazomicin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Synflorix Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Viral Pneumonia Consumption and Growth Rate (2017-2022)
10 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tedizolid Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ceftolozane/Tazobactam Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ceftazidime/Avibactum Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Amikacin Inhale Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Plazomicin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Synflorix Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Viral Pneumonia Consumption Forecast and Growth Rate (2022-2028)
11 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Competitive Analysis
-
14.1 Achaogen
-
14.1.1 Achaogen Company Details
-
14.1.2 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.2 Meiji Seika Pharma
-
14.2.1 Meiji Seika Pharma Company Details
-
14.2.2 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.3 Valneva
-
14.3.1 Valneva Company Details
-
14.3.2 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.6 Aridis Pharmaceuticals
-
14.6.1 Aridis Pharmaceuticals Company Details
-
14.6.2 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.7 Cubist Pharmaceuticals
-
14.7.1 Cubist Pharmaceuticals Company Details
-
14.7.2 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.8 Merck
-
14.8.1 Merck Company Details
-
14.8.2 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
-
Figure Pipeline Analysis of Hospital Acquired Pneumonia Drugs Picture
-
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Country (2017-2022)
-
Figure United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tedizolid Phosphate Consumption and Growth Rate (2017-2022)
-
Figure Global Ceftolozane/Tazobactam Consumption and Growth Rate (2017-2022)
-
Figure Global Ceftazidime/Avibactum Consumption and Growth Rate (2017-2022)
-
Figure Global Amikacin Inhale Consumption and Growth Rate (2017-2022)
-
Figure Global Plazomicin Consumption and Growth Rate (2017-2022)
-
Figure Global Synflorix Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Tedizolid Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ceftolozane/Tazobactam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ceftazidime/Avibactum Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amikacin Inhale Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plazomicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Synflorix Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viral Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Achaogen (Foundation Year, Company Profile and etc.)
-
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Meiji Seika Pharma (Foundation Year, Company Profile and etc.)
-
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Valneva (Foundation Year, Company Profile and etc.)
-
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Aridis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Cubist Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product and Service
-
